Studies Conducted at Zhejiang University on Disease Progression Recently Reported (Oxaliplatin Plus Irinotecan Vs Irinotecan As Second-line Treatment In Pancreatic Cancer Patients: a Randomized-controlled Open-label Phase Ii Study)

Media coverage

• Title	Studies Conducted at Zhejiang University on Disease Progression Recently Reported (Oxaliplatin Plus Irinotecan Vs Irinotecan As Second-line Treatment In Pancreatic Cancer Patients: a Randomized-controlled Open-label Phase Ii Study)
  Media name/outlet	Disease Prevention Daily
  Country/Territory	United States
  Date	3/7/23
  URL	ct.moreover.com/?a=50189027300&p=1gw&v=1&x=bl20rQhjhG7ZmXBAVs0uGQ
  Persons	Yi Zheng